vs

Side-by-side financial comparison of Ralph Lauren Corporation (RL) and ResMed (RMD). Click either name above to swap in a different company.

Ralph Lauren Corporation is the larger business by last-quarter revenue ($2.4B vs $1.4B, roughly 1.7× ResMed). ResMed runs the higher net margin — 27.6% vs 15.0%, a 12.6% gap on every dollar of revenue. On growth, Ralph Lauren Corporation posted the faster year-over-year revenue change (12.2% vs 11.0%). Over the past eight quarters, Ralph Lauren Corporation's revenue compounded faster (23.9% CAGR vs 7.9%).

Ralph Lauren is an American fashion designer, philanthropist, and billionaire businessman, best known for founding the brand Ralph Lauren, a global multibillion-dollar enterprise. He stepped down as CEO of the company in September 2015 but remains executive chairman and chief creative officer. As of May 2025, his net worth is estimated at US$11.9 billion.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

RL vs RMD — Head-to-Head

Bigger by revenue
RL
RL
1.7× larger
RL
$2.4B
$1.4B
RMD
Growing faster (revenue YoY)
RL
RL
+1.3% gap
RL
12.2%
11.0%
RMD
Higher net margin
RMD
RMD
12.6% more per $
RMD
27.6%
15.0%
RL
Faster 2-yr revenue CAGR
RL
RL
Annualised
RL
23.9%
7.9%
RMD

Income Statement — Q3 FY2026 vs Q4 FY2026

Metric
RL
RL
RMD
RMD
Revenue
$2.4B
$1.4B
Net Profit
$361.6M
$392.6M
Gross Margin
69.9%
61.8%
Operating Margin
19.6%
34.6%
Net Margin
15.0%
27.6%
Revenue YoY
12.2%
11.0%
Net Profit YoY
21.6%
13.9%
EPS (diluted)
$5.82
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RL
RL
RMD
RMD
Q2 26
$1.4B
Q4 25
$2.4B
$1.4B
Q3 25
$2.0B
$1.3B
Q2 25
$1.7B
$1.3B
Q1 25
$1.7B
$1.3B
Q4 24
$2.1B
$1.3B
Q3 24
$1.7B
$1.2B
Q2 24
$1.5B
$1.2B
Net Profit
RL
RL
RMD
RMD
Q2 26
$392.6M
Q4 25
$361.6M
$392.6M
Q3 25
$207.5M
$348.5M
Q2 25
$220.4M
$379.7M
Q1 25
$129.0M
$365.0M
Q4 24
$297.4M
$344.6M
Q3 24
$147.9M
$311.4M
Q2 24
$168.6M
$292.2M
Gross Margin
RL
RL
RMD
RMD
Q2 26
61.8%
Q4 25
69.9%
61.8%
Q3 25
68.0%
61.5%
Q2 25
72.3%
60.8%
Q1 25
68.7%
59.3%
Q4 24
68.4%
58.6%
Q3 24
67.0%
58.6%
Q2 24
70.5%
58.5%
Operating Margin
RL
RL
RMD
RMD
Q2 26
34.6%
Q4 25
19.6%
34.6%
Q3 25
12.2%
33.4%
Q2 25
15.9%
33.7%
Q1 25
9.1%
33.0%
Q4 24
18.2%
32.5%
Q3 24
10.4%
31.6%
Q2 24
13.8%
31.2%
Net Margin
RL
RL
RMD
RMD
Q2 26
27.6%
Q4 25
15.0%
27.6%
Q3 25
10.3%
26.1%
Q2 25
12.8%
28.2%
Q1 25
7.6%
28.3%
Q4 24
13.9%
26.9%
Q3 24
8.6%
25.4%
Q2 24
11.1%
23.9%
EPS (diluted)
RL
RL
RMD
RMD
Q2 26
$2.68
Q4 25
$5.82
$2.68
Q3 25
$3.32
$2.37
Q2 25
$3.52
$2.58
Q1 25
$2.03
$2.48
Q4 24
$4.66
$2.34
Q3 24
$2.31
$2.11
Q2 24
$2.61
$1.97

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RL
RL
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$2.3B
$1.4B
Total DebtLower is stronger
$663.8M
Stockholders' EquityBook value
$2.9B
$6.3B
Total Assets
$7.8B
$8.5B
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RL
RL
RMD
RMD
Q2 26
$1.4B
Q4 25
$2.3B
$1.4B
Q3 25
$1.6B
$1.4B
Q2 25
$2.3B
$1.2B
Q1 25
$2.1B
$932.7M
Q4 24
$2.1B
$521.9M
Q3 24
$1.7B
$426.4M
Q2 24
$1.8B
$238.4M
Total Debt
RL
RL
RMD
RMD
Q2 26
$663.8M
Q4 25
$403.9M
Q3 25
$408.7M
Q2 25
$658.4M
Q1 25
$663.1M
Q4 24
$662.9M
Q3 24
$667.6M
Q2 24
$697.3M
Stockholders' Equity
RL
RL
RMD
RMD
Q2 26
$6.3B
Q4 25
$2.9B
$6.3B
Q3 25
$2.6B
$6.1B
Q2 25
$2.5B
$6.0B
Q1 25
$2.6B
$5.5B
Q4 24
$2.5B
$5.3B
Q3 24
$2.4B
$5.2B
Q2 24
$2.4B
$4.9B
Total Assets
RL
RL
RMD
RMD
Q2 26
$8.5B
Q4 25
$7.8B
$8.5B
Q3 25
$7.3B
$8.3B
Q2 25
$7.8B
$8.2B
Q1 25
$7.0B
$7.6B
Q4 24
$7.1B
$7.1B
Q3 24
$6.8B
$7.2B
Q2 24
$6.6B
$6.9B
Debt / Equity
RL
RL
RMD
RMD
Q2 26
0.11×
Q4 25
0.06×
Q3 25
0.07×
Q2 25
0.11×
Q1 25
0.12×
Q4 24
0.13×
Q3 24
0.13×
Q2 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RL
RL
RMD
RMD
Operating Cash FlowLast quarter
$779.6M
Free Cash FlowOCF − Capex
$704.0M
FCF MarginFCF / Revenue
29.3%
Capex IntensityCapex / Revenue
3.1%
Cash ConversionOCF / Net Profit
2.16×
TTM Free Cash FlowTrailing 4 quarters
$694.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RL
RL
RMD
RMD
Q2 26
Q4 25
$779.6M
$339.7M
Q3 25
$53.2M
$457.3M
Q2 25
$176.1M
$538.8M
Q1 25
$122.2M
$578.7M
Q4 24
$738.4M
$308.6M
Q3 24
$97.2M
$325.5M
Q2 24
$277.3M
$440.1M
Free Cash Flow
RL
RL
RMD
RMD
Q2 26
Q4 25
$704.0M
$311.2M
Q3 25
$-40.6M
$414.4M
Q2 25
$-11.2M
$508.2M
Q1 25
$42.3M
$557.9M
Q4 24
$677.2M
$288.0M
Q3 24
$55.5M
$307.7M
Q2 24
$243.9M
$415.2M
FCF Margin
RL
RL
RMD
RMD
Q2 26
Q4 25
29.3%
21.9%
Q3 25
-2.0%
31.0%
Q2 25
-0.7%
37.7%
Q1 25
2.5%
43.2%
Q4 24
31.6%
22.5%
Q3 24
3.2%
25.1%
Q2 24
16.1%
33.9%
Capex Intensity
RL
RL
RMD
RMD
Q2 26
Q4 25
3.1%
2.0%
Q3 25
4.7%
3.2%
Q2 25
10.9%
2.3%
Q1 25
4.7%
1.6%
Q4 24
2.9%
1.6%
Q3 24
2.4%
1.5%
Q2 24
2.2%
2.0%
Cash Conversion
RL
RL
RMD
RMD
Q2 26
Q4 25
2.16×
0.87×
Q3 25
0.26×
1.31×
Q2 25
0.80×
1.42×
Q1 25
0.95×
1.59×
Q4 24
2.48×
0.90×
Q3 24
0.66×
1.05×
Q2 24
1.64×
1.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons